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effects of Az receptor activation, adenosine A 1 receptor 
activation during reperfusion may exacerbate r perfusion 
injury by promoting neutrophil adherence to endotheli- 
urn. 4 
The aforementioned studies emphasize the importance 
of the timing of adenosine treatment. There also remains 
one unexplained ifference between adenosine pretreat- 
ment effects on reversible and irreversible injury. A tran- 
sient adenosine infusion (adenosine preconditioning) that 
is terminated before the onset of ischemia can reduce 
infarct size 3 but does not attenuate stunning. 5 Regard- 
less of the mechanisms of adenosine-mediated cardio- 
protection and the optimal timing of adenosine infu- 
sion, there is evidence that adenosine pretreatment and 
supplementation of blood cardioplegic solution with 
adenosine may be beneficial in the setting of cardiac 
operations in human beings. 6 Finally, we also agree 
with Vinten-Johansen and Hammon that additional 
experimental nd clinical studies are needed to deter- 
mine the mechanism(s) and optimal timing/dose of 
adenosine-mediated cardioprotection. 
Robert D. Lasley, PhD 
Robert M. Mentzer, Jr, MD 
Department of Surgery 
University of Wisconsin School of Medicine 
Room H4/383 Clinical Science Center 
600 Highland Ave. 
Madison, WI 53792 
REFERENCES 
1. Randhawa MPS, Lasley RD, Mentzer RM Jr. Salutary effects 
of exogenous adenosine administration on in vivo myocardial 
stunning. J Thorac Cardiovasc Surg 1995;110:64-74. 
2. Van Wylen DGL. Relationship between intracoronary aden- 
osine, interstitial fluid purine metabolites, and coronary blood 
flow. Drug Develop Res 1994;3l:330. 
3. Lasley RD, Konyn PJ, Hegge JO, Mentzer RM Jr. The effects 
of ischemic and adenosine preconditioning oninterstitial fluid 
adenosine and myocardial infarct size. Am J Physiol 1995;269: 
H1460-6. 
4. Schwartz LM, Raschke P, Becker BF, Gerlach E. Adenosine 
contributes to neutrophil-mediated lossof myocardial func- 
tion in postischemic guinea pig hearts. J Mol Cell Cardiol 
1993;25:927-38. 
5. Sekili S, Jeroudi MO, Tang XL, Zughaib M, Sun JZ, Bolli R. 
Effect of adenosine on myocardial "stunning" in the dog. Circ 
Res 1995;76:82-94. 
6. Mentzer RM Jr, Canver CC, Chopra PS, Love RB, Rahko PS, 
Hegge JO, et al. Efficacy of adenosine as an additive to blood 
cardioplegia in humans during open-heart surgery. Circulation 
1995;92(Suppl I):I762. 
12/8/73245 
Perfusion pressure and coronary bypass 
To the Editor: 
From their prospective study of 248 patients undergo- 
ing first-time coronary bypass, Gold and associates 1 con- 
cluded that higher perfusion pressures during cardio- 
pulmonary bypass improved all outcomes of operation. 
The authors would have us believe that increasing mean 
perfusion pressure from 52 to 70 mm Hg (Table IIIa: 
mean pressure recorded at all flows) for 90 minutes of 
cardiopulmonary bypass reduced permanent cardiac 
complications, reduced neurologic complications, and 
eliminated two deaths (one from multisystem failure 
and one from lung cancer) at 6 months after the 
operations. The incidences of cardiac complications, 
neurologic omplications, and death in the high-pres- 
sure compared with the low-pressure groups were not 
significantly different at the conventionalp < 0.05 level. 
When these outcomes were selectively pooled, however 
(congestive heart failure, minor neurologic deficits, 
cognitive outcomes, and deterioration i quality of life 
were arbitrairily omitted), a significant difference in 
"overall" outcome of morbidity and mortality was 
claimed (p < 0.026). 
As a justification for pooling outcomes, the authors 
invoked a common mechanism, namely, that the low- 
pressure group was "below the autoregulatory limits of 
the coronary and cerebral circulations." Autoregulation of
the cerebral circulation provides constancy of cerebral 
blood flow through a wide range of perfusion pressures, 
including 52 mm Hg. No such pressure-related autoregu- 
latory phenomenon occurs in the coronary circulation. 
Furthermore, the coronary circulation was not perfused 
at all during half of the bypass period because the aorta 
was crossclamped, and o data on the prevalence of 
postbypass and postoperative hypotension or hyperten- 
sion were included, even though these events are not 
rare. To ascribe all, albeit not significant, differences in 
postoperative cardiac omplications for 6 postoperative 
months to 45 minutes of perfusion at 18 mm Hg higher 
pressure during partial aortic occlusion bypass is diffi- 
cult to accept. 
In a separate publication 2 1 year earlier these same 
authors reported studies of cerebral embolization by 
transcranial Doppler sonography in 20 patients undergo- 
ing coronary bypass who appear to be a subset of the 248 
patients in the present study. They reported that postop- 
erative neurocognitive d terioration after coronary bypass 
was directly related to the embolic load to the brain, which 
was greatest at unclamping an atherosclerotic aorta dur- 
ing the operation. One patient among the three with the 
highest embolic load had a stroke during the operation. 
The present study did not include data on cerebral 
embolic load or on grading of atheromatous plaque of the 
aorta. Because the nonsignificant difference in neurologic 
outcome between the high- and low-pressure groups was 
the largest contributor to the difference in "overall" 
outcome, differences in the presence of aortic atheroma- 
tous disease between the two groups could completely 
explain the observed differences in outcome, without 
invoking differences in perfusion pressure. As the authors 
themselves state, "Clear relationships between the sever- 
ity of aortic disease, the number of ES [embolic signals] at 
cross clamp removal and neuropsychological outcome 
must be demonstrated before modification of surgical 
techniques are indicated. ''2 This caveat would and should 
The Journal of Thoracic and 
Cardiovascular Surgery 
Volume 112, Number 1 
Letters to the Editor 2 0 5 
equally apply to management of perfusion pressure during 
cardiac operations as well. 
Arthur S. Keats, MD 
Division of Cardiovascular Anesthesiology 
Texas Heart Institute 
Houston, TX 77225-0345 
Stephen Slogoff, MD 
Department of Anesthesiology 
Loyola University Medical Center 
Maywood, IL 
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Reply to the Editor." 
The members of the Cornell Coronary Artery Bypass 
Outcomes Trial Group (CCABOT) thank Drs. Keats and 
Slogoff for their insightful comments and appreciate the 
opportunity to expand on the points that they have raised 
in their letter regarding our article, a The trial was de- 
signed as a prospective randomized study at the outset. 
The criteria for major and minor outcomes were set a 
priori. The principal outcomes were as follows: all cause 
mortality, cardiopulmonary morbidity (myocardial infarc- 
tion, pulmonary edema, adult respiratory distress syn- 
drome, cardiogenic shock/low flow state, and cardiopul- 
monary arrest), neurologic morbidity (new major focal 
deficit), cognitive complications (defined by intrapatient 
deterioration on neurocognitive t sts), and deterioration 
in functional status (decline on the SF-36 health survey). 
Minor outcomes were also determined a priori and were 
not included as principal outcomes. The minor cardiac 
outcomes included myocardial ischemia and congestive 
heart failure and the minor neurologic outcomes included 
focal deficit lasting less than 24 hours. All major and 
minor outcomes were counted up to the 6-month interval 
after the operation and were stipulated before the start of 
the trial. 
When the major outcomes were analyzed at the com- 
pletion of the trial, it was found that patients randomized 
to the low mean arterial pressure (MAP) group had a 
higher incidence of all cause death, major cardiac ompli- 
cations, and major neurologic omplications. The com- 
bined incidence of total mortality and major cardiac and 
neurologic morbidity was 12.9% in the low MAP group 
versus 4.8% in the high MAP group (p = 0.026). The 
incidence of deterioration i neurocognitive function and 
deterioration i  functional status did not differ between 
the two groups. 
The mean arterial pressures between the low and high 
MAP groups differed by an average of 18 mm Hg. As 
shown in Table VI (the pragmatic analysis), which dem- 
onstrates the actual pressure achieved regardless of ran- 
domization group, the trend toward lower complications 
with higher pressures can clearly be seen. 
Although it is tempting to ascribe differences in out- 
come to variables other than the therapeutic maneuver, 
which was assigned by randomization, it is extremely 
unlikely that the pattern of specific variables differed 
appreciably between the two MAP groups. The very 
raison d'6tre of a randomized trial is the statistical balance 
of potential confounding factors, both those previously 
identified and those unknown at the inception of the trial. 
Table I of the article demonstrates this balance for a large 
number of such variables. Furthermore, although not 
incorporated into the paper, many additional factors were 
analyzed to ascertain whether there were any differences 
between the two MAP groups, either before or after 
bypass. All of these items, including MAPs, cardiac out- 
puts, anesthetic agents, vasoactive medications, other 
medications, blood gases, activated clotting times, hemat- 
ocrit values, and other hemodynamic parameters were not 
found to differ between the two treatment groups. 
Pilot subsets of patients enrolled in the present trial also 
underwent preoperative transesophageal chocardiogram 
and intraoperative transcranial Doppler ultrasonography; 
because these subsets were selected after randomization 
and were examined in a nonrandom fashion, they cannot 
yield unbiased information on the importance of athero- 
matous disease or embolic load for the entire 248-patient 
cohort randomized to two treatment arms. Because ath- 
eromatous disease of the aorta is now thought o be a risk 
factor for perioperative complications of coronary by- 
pass, 2the reproducible quantification of aortic atheroma 
by transesophageal echocardiography is under develop- 
ment. 3Future clinical trials of coronary bypass will incor- 
porate these procedures in all patients. 
Animal and human data support the conclusion that 
autoregulation f cerebral blood flow occurs across the range 
of MAPs of 50 to 150 mm Hg. As observed, 54 mm Hg falls 
within this range. However, the data also suggest that the 
autoregulatory range of cerebral blood flow is shifted to the 
right in patients with longstanding hypertension. In addition, 
these conclusions are based on experiments inwhich global 
cerebral blood flow was measured uring the conditions of 
normothermic pulsatile peffusion. Extension of these con- 
clusions to the conditions of nonpulsatile, hypothermic by- 
pass with attention to regional blood flow may not be valid. 
Patients with coronary artery disease are known to have an 
increased incidence of other vascular disease, including that 
of the cerebral circulation. Higher perfusion pressures may 
permit the maintenance of adequate blood flow to areas 
distal to stenotic vessels or facilitate recruitment ofcollateral 
blood flow, thus minimizing the affected area of ischemia. 
Jeffrey P. Gold, MD 
Department of Cardiothoracic Surgery 
The New York Hospital Cornell Medical Center 
New York, NY 10021 
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